Leading TechBio Investment Firm ARTIS Ventures Announces 2023 Class of Healthcare and Life Sciences Fellows
January 12, 2024 12:00 ET
|
ARTIS Ventures
San Francisco, CA, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced its newest class of AV Fellows. Selected from...
Delivering Next Generation Addiction Recovery, Affect Therapeutics Raises $16 Million in Series A Funding Led by ARTIS Ventures
July 12, 2023 07:00 ET
|
ARTIS Ventures
McLean, VA, July 12, 2023 (GLOBE NEWSWIRE) -- Affect Therapeutics (“Affect”), a company reimagining addiction treatment for the digital age, today announces a $16 million Series A led by...
With the Potential to Revolutionize Personalized Health, Range Biotechnologies Receives $5.2 Million in Seed Funding Led by TechBio-Focused ARTIS Ventures
June 12, 2023 11:00 ET
|
ARTIS Ventures
San Francisco, CA, June 12, 2023 (GLOBE NEWSWIRE) -- Range Biotechnologies (“Range Bio”), a proteomics-focused biotech company that has developed an innovative translational platform to enable...
Leading TechBio Investment Firm ARTIS Ventures Announces 2022 Class of Healthcare and Life Sciences Fellows
December 14, 2022 11:00 ET
|
ARTIS Ventures
San Francisco , Dec. 14, 2022 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced its newest class of AV Fellows. The 2022 fellows...
ARTIS Ventures Welcomes Henry Klingenstein to Its Investment Team
October 10, 2022 11:00 ET
|
ARTIS Ventures
San Francisco, Oct. 10, 2022 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced Henry Klingenstein has joined the investment...
ARTIS Ventures Promotes Ameena El-Bibany to Partner
December 15, 2021 10:40 ET
|
ARTIS Ventures
San Francisco, CA, Dec. 15, 2021 (GLOBE NEWSWIRE) -- ARTIS Ventures, a San Francisco-based venture firm focused on pioneering investments at the intersection of life sciences and computer sciences,...
ARTIS Ventures Announces 2021 Class of Healthcare and Life Sciences Fellows
August 03, 2021 13:13 ET
|
ARTIS Ventures
San Francisco, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- ARTIS Ventures (“AV”), a venture firm focused on pioneering investments in biotech, health, and life sciences, today announced the candidates...
Creating Next Generation Smart Cell Therapies: Outpace Bio Receives $30 Million in Series A Funding Led by ARTIS Ventures and Lyell Immunopharma Inc.
March 31, 2021 09:00 ET
|
ARTIS Ventures
Seattle, WA, March 31, 2021 (GLOBE NEWSWIRE) -- Outpace Bio, a biotechnology company building a platform to create next-generation smart cell therapies, today announced the closing of a $30 million...
Second Front Systems Raises $6 Million to Provide Immediate Impact to National Security, led by ARTIS Ventures
July 07, 2020 11:00 ET
|
ARTIS Ventures
San Francisco, CA, July 07, 2020 (GLOBE NEWSWIRE) -- Second Front Systems, a software company working to disrupt the traditional aerospace and defense industry by acting as a beachhead for...
ARTIS Ventures Welcomes Jeff Kindler as Operating Partner
April 20, 2020 12:00 ET
|
ARTIS Ventures
SAN FRANCISCO, April 20, 2020 (GLOBE NEWSWIRE) -- ARTIS Ventures, a venture firm focused on pioneering investments at the intersection of life sciences and computer sciences, today announced that...